Cannabinoids have limited impact on MS symptoms

Following a systematic review and meta-analysis, Spain’s Universitat Autònoma de Barcelona, Hospital Universitari Germans Trias i Pujol and Institut de Neuropsiquiatria i Addiccions concluded that cannabinoids have limited therapeutic effect in improving the symptoms of multiple sclerosis. There was no significant impact on objectively measured spasticity.